Samuel Drew is a Principal Scientist specializing in CMC and process development with over seven years of experience in the pharmaceutical industry. They have contributed significantly at Gilead Sciences and Arcus Biosciences, focusing on drug discovery and the synthesis of novel compounds. Samuel earned a Doctor of Philosophy in Organic Chemistry from The Australian National University and also holds a Bachelor’s Degree in Chemistry from the University of Canterbury. Their postdoctoral research includes work on natural product synthesis and medicinal chemistry programs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices